Even though the pathogenicity and invasiveness of pneumococcus largely depend on capsular types, the impact of serotypes on post-viral pneumococcal pneumonia is unknown.<0.01). Multivariate analysis revealed several statistically significant risk factors for post-viral pneumococcal pneumonia: immunodeficiency (OR 1.66; 95% CI, 1.10–2.53), chronic lung diseases (OR 1.43; 95% CI, 1.09–1.93) and ICI serotypes (OR 4.66; 95% CI, 2.07–10.47).Infrequently colonizing invasive serotypes would be more likely to cause pneumococcal pneumonia after preceding respiratory viral illness, particularly in patients with immunodeficiency or chronic lung diseases
Background. The 13-valent pneumococcal conjugate vaccine (PCV13) has recently been approved for use ...
Background. The 13-valent pneumococcal conjugate vaccine (PCV13) has recently been approved for use ...
Background. The 13-valent pneumococcal conjugate vaccine (PCV13) has recently been approved for use ...
<div><p>Background</p><p>Even though the pathogenicity and invasiveness of pneumococcus largely depe...
<p>ICI, infrequently colonizing but invasive serotypes; FCI, frequently colonizing and invasive sero...
<p>*Two null capsule clade (NCC) 1 isolates, one NCC2 isolate, and two NCC3 isolates.</p><p>ICI, inf...
Background. The 92 capsular serotypes of Streptococcus pneumoniae differ greatly in nasopharyngeal c...
Defining the propensity of Streptococcus pneumoniae (SP) serotypes to invade sterile body sites foll...
Background: There is limited knowledge of serotypes that cause non-bacteremic pneumococcal pneumonia...
There is limited knowledge of serotypes that cause non-bacteremic pneumococcal pneumonia (NBP). Here...
Influenza A virus (IAV) and Streptococcus pneumoniae (S. pn.) are major causes of respiratory tract ...
We studied the immunoglobulin (Ig) response to causative serotype-specific capsular polysaccharides ...
Defining the propensity of Streptococcus pneumoniae (SP) serotypes to invade sterile body sites foll...
BACKGROUND:Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13) has reduced invasi...
Background: Vaccination of infants with pneumococcal conjugate vaccines (PCV) has resulted in major ...
Background. The 13-valent pneumococcal conjugate vaccine (PCV13) has recently been approved for use ...
Background. The 13-valent pneumococcal conjugate vaccine (PCV13) has recently been approved for use ...
Background. The 13-valent pneumococcal conjugate vaccine (PCV13) has recently been approved for use ...
<div><p>Background</p><p>Even though the pathogenicity and invasiveness of pneumococcus largely depe...
<p>ICI, infrequently colonizing but invasive serotypes; FCI, frequently colonizing and invasive sero...
<p>*Two null capsule clade (NCC) 1 isolates, one NCC2 isolate, and two NCC3 isolates.</p><p>ICI, inf...
Background. The 92 capsular serotypes of Streptococcus pneumoniae differ greatly in nasopharyngeal c...
Defining the propensity of Streptococcus pneumoniae (SP) serotypes to invade sterile body sites foll...
Background: There is limited knowledge of serotypes that cause non-bacteremic pneumococcal pneumonia...
There is limited knowledge of serotypes that cause non-bacteremic pneumococcal pneumonia (NBP). Here...
Influenza A virus (IAV) and Streptococcus pneumoniae (S. pn.) are major causes of respiratory tract ...
We studied the immunoglobulin (Ig) response to causative serotype-specific capsular polysaccharides ...
Defining the propensity of Streptococcus pneumoniae (SP) serotypes to invade sterile body sites foll...
BACKGROUND:Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13) has reduced invasi...
Background: Vaccination of infants with pneumococcal conjugate vaccines (PCV) has resulted in major ...
Background. The 13-valent pneumococcal conjugate vaccine (PCV13) has recently been approved for use ...
Background. The 13-valent pneumococcal conjugate vaccine (PCV13) has recently been approved for use ...
Background. The 13-valent pneumococcal conjugate vaccine (PCV13) has recently been approved for use ...